Trial Profile
Pharmacokinetics and pharmacodynamics of lixisenatide in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2020
Price :
$35
*
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 15 Sep 2017 Results assessing the impact of lixisenatide dose range on glycaemic outcomes in three studies (ACT6011, DRI6012 and LixiLan-O), presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 16 Oct 2012 Results from a subset of patients receiving once-daily lixisenatide investigating gastric emptying and the relationship to postprandial glycaemia have been reported as an abstract at EASD 2012.
- 05 Nov 2010 New trial record.